Leaders of hospitals and health systems face an array of difficult challenges as they move into 2023. In light of the challenges providers face, the Veralon team has identified high-impact initiatives that may help systems turn the corner for a brighter 2023. Briefly, the challenges include: Weakened balance sheets that limit capital available for new […]
Analyzing and prioritizing service lines like a portfolio can support focused growth, even during a financial crisis. Cost cutting is critical but insufficient to ensure viability and success when the financial crisis faced by health systems is prolonged, as it has been in 2022. Health systems must also grow revenue. Tight budgets and limited access […]
Seventy percent of healthcare executives expect more mergers and acquisitions across healthcare sectors in 2022, a KPMG survey found, while 30 percent of healthcare investors plan to increase deal activity by 10 percent or more. For hospital and health system leaders, it’s a good time to consider: What’s your business case for M&A? We’ve seen […]
Amazon made a major move into healthcare in July when it announced plans to buy One Medical in a $3.9 billion deal. Suddenly, theoretical discussions about the future of healthcare—a future that could be dominated by tech giants such as Amazon, Google and Apple—came into sharp focus as the potential for Amazon to reinvent primary […]
Host Ericka Adler, Roetzel shareholder and Health Law Practice Group Leader, is joined by fellow Roetzel shareholder David Hochman, and special guest Dan Grauman, Veralon Managing Director and CEO, to discuss evaluating and planning for healthcare practice mergers and acquisitions. Dan Grauman talks about the ongoing trends of consolidation he sees in healthcare, the important […]
One of the most important considerations in finalizing a healthcare merger is how well the consolidated entity will perform, financially, after the deal is complete. Many times, leaders get so caught up in the blocking-and-tackling of due diligence—a time-consuming exercise that protects their organization from material risk—that their ability to see past the point of […]
This clinically integrated network (“CIN”) had a track record of success, but was still leaving money on the table. Did they need to achieve formal CIN designation? Would one model of physician participation accommodate all types of interested physicians? Contact our Thought Leaders: John Harris, Managing Director, jharris@veralon.com Molly Johnson, Consultant, mjohnson@veralon.com
Challenge: Design a strategy to become the market leader for oncology services across a broad region that accounted for implications of emerging trends specific to: incidence of tumor sites, population, evolution of care, competitor vulnerabilities, and oncology reimbursement. Contact our Thought Leader: Mark Dubow, Director, mdubow@veralon.com
It’s not easy to determine if there is equity in provider compensation across your organization, given the many departments, specialties, and roles—but it’s essential. Consider the following hypothetical: A local news source reports a 30% pay discrepancy between your male and female maintenance employees performing the same work. Chances are you would rather not have […]
Health systems and their Clinically Integrated Networks (CINs) face threats from a variety of competitors, including market disruptors, that may lure away aligned independent physicians and patients. Although the landscape of these competitors differs by market, they threaten the core business of CINs and complicate health system alignment with independent physician groups. Contact the Author: […]